An2 Therapeutics, Inc.NASDAQ: ANTX

AN2 Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business and Scientific Highlights

· Issued by An2 Therapeutics, Inc.

The original release is unavailable here.